Clinical Trial Results: Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating CT7001 as a single-agent therapy in adults with advanced solid malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Malignancies

Drugs mentioned

• CT7001

Snippet

Sponsor: Carrick Therapeutics Limited | Conditions: Advanced Solid Malignancies | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-06-23